Skip to main content
. 2009 Apr 15;83(13):6652–6663. doi: 10.1128/JVI.00260-09

TABLE 2.

Effect of silencing and HSV-1 infection on mRNA half-life

Infection mRNA half-life (h) of:
EGFP
β-Actin
Silenceda Controlb Silenceda Controlb
Nonec 2.8* (2.6-3.1) 5.5 (5.2-5.7) 21.7 (19.9-23.4) 21.9 (20.1-23.1)
Mockd 2.7* (2.6-3.0) 5.4 (5.1-5.6) 20.4 (19.8-21.1) 21.2 (20.3-22.1)
Wild-type (KOS)d 4.5** (4.3-4.6) 4.1** (3.9-4.3) 15.5** (15.0-16.1) 15.4** (14.9-16.2)
Mocke 2.8* (2.5-3.0) 5.5 (5.3-5.8) 20.6 (19.3-22.1) 21.6 (20.1-22.8)
vhs-1e 5.6** (5.3-5.8) 5.4 (5.3-5.7) 21.1 (19.8-22.6) 20.5 (19.6-22.3)
27-LacZe 5.3** (5.2-5.6) 5.7 (5.4-5.9) 20.5 (18.9-22.1) 20.5 (19.1-21.9)
a

BHK cells were cotransfected with equimolar amounts of EGFP target-expressing and dsEGFP hairpin-expressing plasmids. The mRNA amounts (normalized to the 18S rRNA level) were determined from Northern blots probed first by hybridization with EGFP-specific sequences. Blots were stripped and subsequently hybridized to a β-actin-specific probe. Half-lives were estimated by fitting the data to an exponential decay function as described in Materials and Methods. Nonlinear regression analysis was performed, and the 95% confidence intervals for the estimated half-lives are shown in parentheses. A single asterisk indicates that the half-life estimates of silenced compared to control samples for each mRNA type were significantly different (P < 0.05). Double asterisks indicate that estimated half-lives of a particular mRNA type in infected samples were significantly different (P < 0.05) from those in mock-infected samples.

b

BHK cells were cotransfected with equimolar amounts of EGFP target-expressing and dslacZ hairpin-expressing plasmids. Half-lives were estimated and compared for differences as described in Materials and Methods and footnote a.

c

Cells were cotransfected with target- and hairpin-expressing plasmids as indicated, and Act D (5 μg/ml) was added 52 h later. RNA levels were determined at various times after the addition of Act D.

d

Cells were cotransfected with target- and hairpin-expressing plasmids as indicated, and 42 h later, cells were either mock infected or infected with wild-type (KOS) virus at an input MOI of 5 PFU/cell. Act D (5 μg/ml) was added 6 h after infection or mock infection, and mRNA levels were determined at various times thereafter.

e

Experiment was performed as described above except that cells were either mock infected or infected with the vhs-1 or 27-LacZ virus mutant (MOI of 5 PFU/cell).